How do you decide which patients would benefit from ECAP-closed loop spinal cord stimulation?

The EVOKE trial enrolled patients with chronic, intractable back and leg pain refractory to conservative therapy - including both persistent spinal pain syndrome (PSPS) type 1 and 2, with the following eligibility criteria:

• Overall, back, and leg pain VAS ≥60 mm
• Oswestry Disability Index 41–80
• Stab...